DSM Nutritional Products, LLC
Letter data
- Company
- DSM Nutritional Products, LLC
- Recipient
- Chris Goppelsroeder | President | DSM Nutritional Products, LLC | 45 Waterview Blvd. | Parsippany | , | NJ | 07054 | United States
- Issue date
- 2020-06-03
- Posted date
- Not available
- FDA office
- Human & Animal Food Operations, West Division 3
- Subject
- Not available
- Product
- Animal & Veterinary
- CMS ID
- 578300
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
DSM Nutritional Products, LLC
MARCS-CMS 578300 —
June 03, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
UPS Overnight
Product:
Animal & Veterinary
Recipient:
Recipient Name
Chris Goppelsroeder
Recipient Title
President
DSM Nutritional Products, LLC
45 Waterview Blvd.
Parsippany
,
NJ
07054
United States
Issuing Office:
Human & Animal Food Operations, West Division 3
United States
Dear Mr. Goppelsroeder:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS 578300 dated October 11, 2019) issued following an inspection of your vitamin and mineral premix animal food manufacturing facility located at 5101 Rondo Dr., Fort Worth, TX 76106. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Jessica E. Havranek
Director, Compliance Branch
Human & Animal Food Operations, WD3
Cc:
Stephen J. Gristina, Director of Premix Operations – North America
DSM Nutritional Products, North America
45 Waterview Blvd.
Parsippany, NJ 07054
Lance Collard, Plant Manager
DSM Nutritional Products, LLC
5101 Rondo Drive
Fort Worth, TX 76106
Office of Texas State Chemists
Dr. Timothy Herrman
445 Agronomy Road
College Station, TX 77843
Content current as of:
06/12/2020
Regulated Product(s)
Animal & Veterinary